Rare disease treatment
Total raised: $10M
Investors 1
| Date | Name | Website |
| 11.03.2025 | SymBiosis | symbiosis.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.02.2025 | - | $10M | - |
Mentions in press and media 2
| Date | Title | Description |
| 25.02.2025 | Paradox Immunotherapeutics Receives $10M Investment from SymBiosis | Paradox Immunotherapeutics, a Toronto, Canada-based pharmaceutical company focused on the development of antibody therapies, received a $10M investment from SymBiosis Capital Management. In connection with the funding, Sandy Zweifach, an Op... |
| - | Paradox Immunotherapeutics | “Rare disease treatment” |